Company intelligence / Profile preview

Amoena

Raubling, Bavaria, Germany

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Amoena is the world leader in breast care for women post-breast cancer surgery, offering commercial products including the original silicone breast form, textiles, and accessories to improve quality of life and self-confidence after breast surgery. Products are tailored to women's needs at all points of the recovery and survivorship journey. No pharmaceutical clinical trial data or drug candidates are reported.

Therapeutic areas: OncologyWomen's Health
Modalities: Device
Industry: Assistive Medical Devices

Beyond the preview

Go deeper on Amoena.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amoena.

Explore the full profile